EP Patent

EP1201233A1 — Transdermal dosage form

Assigned to Euro Celtique SA · Expires 2002-05-02 · 24y expired

What this patent protects

A distressing substance is added to opioid analgesic compositions intended for percutaneous administration, in order to prevent drug abuse.

USPTO Abstract

A distressing substance is added to opioid analgesic compositions intended for percutaneous administration, in order to prevent drug abuse.

Drugs covered by this patent

Patent Metadata

Patent number
EP1201233A1
Jurisdiction
EP
Classification
—
Expires
2002-05-02
Drug substance claim
No
Drug product claim
No
Assignee
Euro Celtique SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.